Human Fc gamma RIIA/CD32a (H167) (His-Avi Tag)

SKU: 93441ES25

Size: 25 μg
Price:
Sale price$237.00

Shipping calculated at checkout

Stock:
In stock

Description

Receptors for the Fc region of IgG (Fc gamma R) are members of the Ig superfamily that function in the activation or inhibition of immune responses. Three classes of human Fc gamma Rs: RI (CD64), RII (CD32), and RIII (CD16), which generate multiple isoforms, are recognized. The activating-type receptor either has or associates non-covalently with an accessory subunit (FcR gamma or zeta chain) that has an immunoreceptor tyrosine-based activation motif (ITAM) in its cytoplasmic domain. In contrast, the inhibitory receptor (Fc gamma RIIB) has a built-in immunoreceptor tyrosine-based inhibitory motif (ITIM) in its own cytoplasmic domain. Fc gamma RI is a high-affinity receptor that binds monomeric IgG, both Fc gamma RII and RIII are low-affinity receptors that bind aggregated or immune complexed IgG (IC).The extracellular domain of human Fc gamma RIIA shares approximately 90% amino acid sequence homology with human Fc gamma RIIB and Fc gamma RIIC. Fc gamma RIIA is expressed on many immune cell types (macrophage, neutrophil, eosinophils, platelets, dendritic cells and Langerhan cells) where inhibitory ITIM-bearing receptors may also be coexpressed and co-engaged by specific ligands.

Specifications

Synonyms

Fc gamma RIIA; FCG2; FCGR2; FCGR2A; FCGR2A1; FcgRIIA; FCRIIA; fcRII-a; FCG2; CD32A

Uniprot No.

 P12318-1

Source

Recombinant Human Fc gamma RIIA/CD32a (H167) Protein is expressed from HEK293 Cells with His tag and Avi tag at the C-terminal. It contains Ala36-Ile218(H167).

Molecular Weight

The protein has a predicted MW of 23.2 kDa. Due to glycosylation, the protein migrates to 30-40 kDa based on Tris-Bis PAGE result.

Physical Appearance

Sterile Filtered White lyophilized (freeze-dried) powder.

Purity

> 95% as determined by SDS-PAGE and HPLC

Activity

SPR DataRituximab captured on CM5 Chip via Protein A can bind Human Fc gamma RIIA (H167) , His-Avi Tag with an affinity constant of 0.606 μM as determined in SPR assay.

Endotoxin

< 1.0 EU per 1μg of the protein by the LAL method.

Formulation

Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization.

Reconstitution

Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/mL is recommended (usually we use 1 mg/mL solution for lyophilization). Dissolve the lyophilized protein in distilled water.

Storage  

The product should be stored at -20~-80℃ for 1 year from date of receipt.

2-7 days, 2 ~8 °C under sterile conditions after reconstitution.

3-6 months, -20~-80℃ under sterile conditions after reconstitution.

Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.

Note

1. Avoid repeated freezing and thawing.

2. Please operate with lab coats and disposable gloves, for your safety.    

3. This product is for research use only.    

Product Data

Figure 1. The purity of Human Fc gamma RIIA/CD32a (H167) is greater than 95% as determined by Tris-Bis PAGE and SEC-HPLC.
Figure 2. Rituximab captured on CM5 Chip via ProteinAcan bind Human Fc gamma RIIA(H167), His-Avi Tag with an affinity constant of 0.606μM as determined in SPR assay (Biacore T200)

Payment & Security

American Express Apple Pay Diners Club Discover Google Pay Mastercard Visa

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

Inquiry

You may also like

FAQ

The product is for research purposes only and is not intended for therapeutic or diagnostic use in humans or animals. Products and content are protected by patents, trademarks, and copyrights owned by Yeasen Biotechnology. Trademark symbols indicate the country of origin, not necessarily registration in all regions.

Certain applications may require additional third-party intellectual property rights.

Yeasen is dedicated to ethical science, believing our research should address critical questions while ensuring safety and ethical standards.